바이오 분석 시험 서비스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Bioanalytical Testing Services Market size is expected to reach USD 11.27 Billion in 2034 from USD 5.16 Billion (2025) growing at a CAGR of 9.07% during 2026-2034.

The global bioanalytical testing services market is witnessing significant growth as pharmaceutical and biotechnology companies continue to increase research and development activities. These services are essential in drug development because they analyze biological samples to evaluate drug concentration, metabolism, and safety. As the development of complex biologics and advanced therapies increases, pharmaceutical companies are relying heavily on specialized testing services to ensure compliance with regulatory requirements and maintain drug development efficiency.

One of the key drivers of the market is the rising trend of outsourcing testing services to contract research organizations. Pharmaceutical companies prefer outsourcing because it reduces operational costs and allows them to focus on core research activities. Additionally, the increasing number of clinical trials worldwide is creating strong demand for bioanalytical testing. Technological advancements in analytical instruments, including mass spectrometry and chromatography, are also improving the precision and speed of biological sample analysis.

Looking ahead, the bioanalytical testing services market is expected to grow further as personalized medicine and biologic therapies become more common. Increasing regulatory scrutiny regarding drug safety will also require more detailed testing and validation processes. Emerging markets are expected to play an important role in future expansion as pharmaceutical research activities grow globally. Continuous innovation in analytical technologies will further support market development and improve testing capabilities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Molecule Type

• Small Molecule
• Large Molecule

By Test Type

• Dmpk Testing
• Biomarker Testing
• Virology Testing
• In-Vivo Virology Testing
• In-Vitro Virology Testing
• Serology Testing
• Immunogenicity Testing
• Other Test Types

By Application

• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Applications

By End-Use

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Research & Academic Institutes
• Other End-Users

COMPANIES PROFILED

• BioAgilytix, Charles River Laboratories Inc, Eurofins Scientific, Frontage Labs, ICON Plc, Intertek Group Plc, Labcorp Drug Development, Pace Analytical Services LLC, SGS Socit Gnrale de Surveillance SA, Syneos Health, Thermo Fisher Scientific Inc, WuXi AppTec
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY MOLECULE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Molecule Type
• 4.2. Small Molecule Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Large Molecule Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Dmpk Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biomarker Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Virology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. In-Vivo Virology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. In-Vitro Virology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Serology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Immunogenicity Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Gastroenterology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Molecule Type
  • 8.2.2 By Test Type
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Molecule Type
  • 8.3.2 By Test Type
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Molecule Type
  • 8.4.2 By Test Type
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Molecule Type
  • 8.5.2 By Test Type
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Molecule Type
  • 8.6.2 By Test Type
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOANALYTICAL TESTING SERVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 BioAgilytix
  • 10.2.2 Charles River Laboratories Inc
  • 10.2.3 Eurofins Scientific
  • 10.2.4 Frontage Labs
  • 10.2.5 ICON Plc
  • 10.2.6 Intertek Group Plc
  • 10.2.7 Labcorp Drug Development
  • 10.2.8 Pace Analytical Services LLC
  • 10.2.9 SGS SociAfA(C)TAfA(C) GAfA(C)NAfA(C)Rale De Surveillance SA
  • 10.2.10 Syneos Health
  • 10.2.11 Thermo Fisher Scientific Inc
  • 10.2.12 WuXi AppTec